SCHEMBL8365683

SCHEMBL8365683

CC(C)[C@H]1NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)[C@@H](Cc2ccc(OCCCNC(=O)c3ccc(NN=Cc4ccccc4S)nc3)cc2)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM4A O75164 1/20 0.44
▸ ITGB3 P05106 11/20 0.43
▸ ITGAV P06756 10/20 0.43
▸ ITGB1 P05556 4/20 0.43
▸ ITGA5 P08648 4/20 0.43
▸ ITGB5 P18084 4/20 0.43
▸ CTSG P08311 2/20 0.41
▸ ITGB6 P18564 2/20 0.41
▸ ITGB8 P26012 2/20 0.41
▸ MC4R P32245 4/20 0.41
▸ MC5R P33032 4/20 0.41
▸ MC3R P41968 4/20 0.41
▸ MC1R Q01726 4/20 0.41
▸ ITGA2B P08514 1/20 0.41
▸ NNMT P40261 1/20 0.41
▸ PLAU P00749 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8366260 0.94 AVPR2 (0.42) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL8365687 0.94 AVPR2 (0.42) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL8365685 0.93 AVPR2 (0.43) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL14585800 0.93 KDM4A (0.43) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL7746128 0.93 KDM4A (0.43) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL7738154 0.93 KDM4A (0.43) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL8364168 0.93 ITGB3 (0.42) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL8366358 0.92 ITGB3 (0.40) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL8366264 0.91 ITGB3 (0.42) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL8365734 0.90 ITGB3 (0.46) ITGB3ITGAVITGB1ITGA5ITGB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6537520-B1 Diagnosis and treatment of cancer; kit containing compound having peptide or peptidomimetic functionality that binds to a alpha v beta 3 receptor linked to a chelator BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-03-25 — — US disclosed
Send feedback